Industry News-Good Doctor

Blog

——

2024.09.26

The National Cancer Center has just released: 2024 National Cancer Report

Recently, with the approval of the National Health Commission, the National Cancer Center released the 2022 burden of malignant tumors in China based on the latest data from tumor registration and follow-up monitoring on JNCC. The results released this time are jointly calculated by the National Cancer Center and the International Agency for Research on Cancer (IARC), consistent with the Chinese data published by IARC in GLOBOCAN 2022 and released simultaneously.

2026.06.18

Reprinted: Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)

2026.06.18

Reprinted: Chinese Expert Consensus on the Diagnosis and Treatment of Female Peritoneal Mesothelioma (2026 Edition)

Peritoneal malignant mesothelioma (PMM) is a highly aggressive malignancy originating from peritoneal mesothelial cells. It is often misdiagnosed as a gynecologic malignancy in female patients, and the overall prognosis after diagnosis remains poor.

2026.06.18

Reposted: 2026 Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Gastric Cancer, 2026

Developing diagnostic and treatment guidelines for common malignancies in China—grounded in evidence-based medicine, mindful of the accessibility of clinical products, and incorporating the latest advances in precision medicine—is one of the core missions of the Chinese Society of Clinical Oncology (CSOO). In recent years, a new trend has emerged in the development of clinical practice guidelines: prioritizing the availability of healthcare resources, a approach particularly well-suited to developing countries and to nations and regions characterized by pronounced regional disparities.

2026.06.18

Reprinted: 2026 Expert Consensus on the Clinical Diagnosis and Treatment of Malignant Peritoneal Mesothelioma (English Version)

Expert consensus on the diagnosis and treatment ofmalignant peritoneal mesothelioma

2026.06.18

Reprinted: 2026 Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Malignant Pleural Effusion Associated with Ovarian Cancer (2026 Edition)

Malignant pleural effusion (MPE) refers to pleural fluid accumulation resulting from primary malignant tumors of the pleura or from metastases of malignancies originating elsewhere that have spread to the pleura.

2026.05.27

Reposted: [Commentary] International Cutting-Edge Advances and Clinical Practice in the Diagnosis and Treatment of Pseudomyxoma Peritonei

The academic study of peritoneal pseudomyxoma (PMP) has been long and tortuous; only over the past four decades has a conceptual framework aligned with the core principles of oncology gradually taken shape.

2026.05.27

Good Doctor·Hyperthermic Perfusion | Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Pseudomyxoma Peritonei (PMP)

PMP is a rare clinical syndrome primarily caused by the dissemination and implantation of mucinous tumor cells within the peritoneal cavity, leading to the accumulation of mucinous ascites.

< 1 2 3 4 5 > proceed page

· China Good Doctor ·

· Good friends of human beings ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!